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M it i fon or ng o  
antimicrobial resistance  
– a national example and 
EURL-AR experience
Susanne Karlsmose, Denmark
F t b t D kac s a ou enmar
Population: ~ 5.5 mill
Area: 43.098 km2
Denmark is a major livestock producer in Europe
- and the worlds’ largest exporter of pork
In 2008,
~ 5.800 pig farms (12.7 million pigs)
~ 5.200 dairy farms (575.000 dairy cows (1.6 million cattle in total))
~ 300 with specialised poultry production (3.5 million hens)
• Highly specialised – only 3% has more than one animal 
species
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(The Ministry of Foreign Affairs in Denmark and Danish Agricultural and Food Council)
Classes of antimicrobials used in agriculture
All classes are also used in humans, including 
substances considered Critically Important 
Antimicrobials by WHO for human therapy (e g      . . 
fluoroquinolones, 3rd gen. cephalosporins, 
streptogramins)  
– very few exceptions
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E f i tmergence o  res s ance
What can we do to control it??? Emergence of resistance
– Monitoring of resistance
– Association between antimicrobial use
Origin        Evolution/adaptation         Spread          Multiplication
and resistance
– Spread of resistance from animals to 
humans
Antibiotic 
producing
organisms or
house-keeping
Change of genes to 
new functions and 
adaptation to new 
hosts
Transfer of 
genes 
between
hosts and 
Selection of 
resistant bacteria 
through the use
of antibiotics
– Global spread of foodborne pathogens
– Basic evolution to understand global 
epidemiology
genes reservoirs
Antibiotics 
select
resistant
Antibiotics 
speed up 
transfer
Antibiotics 
speed up 
evolution
variants
DANMAP
Use of antimicrobial agents 
 
and occurrence of antimicrobial 
resistance in bacteria from 
food animals, foods and 
humans in Denmark
The DANMAP programme
• Initiated in 1995
(First report in 1997)
  
   
• Objectives
– Monitor consumption of antimicrobials for food animals and 
humans 
– Monitor the occurrence of antimicrobial resistance among       
bacteria from food animals, food of animal origin and humans
– Study associations between antimicrobial consumption and 
antimicrobial resistance 
– To identify routes of transmission and areas for further research
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The DANMAP participants  
• Statens Serum Institute
• (The Danish Veterinary and Food Administration)
• The Danish Medicines Agency   
• National Food Institute, Technical University of Denmark
• National Veterinary Institute, Technical University of Denmark 
The results are published annually
Considerations (1)
• Purpose of the surveillance programme
Trend–
– Early warning
– Estimate associations between consumption and     
resistance
– Effect of interventions
– Guide to antimicrobial use policies  
• Methods
– identical methods 
– MIC-values
• Active / passive surveillance
Considerations (2)
• Sampling scheme
– The sampling frame should cover all epidemiological unit 
of the national production
– A representative sample collected randomly 
• The epidemiological unit for broilers and turkeys is the flock
• For pigs and cattle the epidemiological unit is the holding         
– Sampling procedure remains constant
• Comparable samples between populations    
Herds 2002 2006 -
DANMAP Herds 2002-2006
Passive surveillance 
Diagnostic submissions from veterinarians and human doctors
Isolates from the existing Salmonella surveillance programmes 
Advantage and disadvantage:
– Low cost, large number of isolates
R ti t ft t t ti– epresen ng wors  cases, o en no  a represen a ve 
sample
Active surveillance 
Extra samples that are collected on our request, we design the 
sampling strategy
The samples are from healthy animals, humans and from foods 
(slaughterhouses, retail outlet e.g. supermarkets)
Advantage and disadvantage:
– Knowledge about the level of resistance in the normal 
population and in food, we have influence on the sampling 
scheme
Each sample has a price often not a large number of–     ,       
isolates
Isolates from food animals   
• Random sampling of herds at slaughter
– Broilers - 95% of population 
– Pigs - 95% of population
– Cattle - 90% of population 
• Diseased population
– Used to be almost 100% national coverage of poultry, 
pigs and cattle
– Decreasing coverage over the past decade
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Isolates from food  
• Samples are collected from pre-determined 
categories 
• Nationwide collection of samples at wholesale 
and retail outlets   
• Imported foods are sampled for Salmonella at 
point of entry
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Isolates from humans
• Results of routine testing of various pathogens in fourteen 
major hospitals 
• Data from testing of Campylobacter and Salmonella
submitted to the central public health laboratory       
• Enterococci and E. coli isolated from stools from approx. 
200 healthy humans 
(random sample 2004-2007; recruits 2008)
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B t i i l d d i th DANMAPac er a nc u e  n e  programme
Genus Indicator Pathogen Zoonotic  
E. coli + +  
E t in erococc +
Staphylococci  +  
Streptococci  +  
Salmonella +
Campylobacter   + 
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EU and Danish government interventions - I
• Since before the 1970s all veterinary medical products have 
been prescription only 
• In 1994 the Central Husbandry Register (National Animal        
Identification System) was established, with national registration 
and identification of every herd in Denmark 
I 1994/95 h l ti f ti i bi l hibit d• n  any prop y ac c use o  an m cro a s was pro e  
and the veterinarians’ profits from direct sales of medicine were 
fixated at a very low level with a maximum of 10% 
• In 1995 preventive veterinary strategies were implemented with 
herd health contracts on a voluntary basis and regular monthly 
visit from the veterinarian, irrespective of the actual herd health          
situation, in order to promote preventive veterinary strategies, 
optimizing antimicrobial use 
In 1995 the DANMAP programme was established•     
EU and Danish government interventions - II
• In 1995, the Danish government banned the non-therapeutic 
use of avoparcin for growth promotion in Denmark (was 
extended to all EU countries in 1997) 
• In January 1998, the Danish government banned the non-
therapeutic use of virginiamycin for growth promotion
I D b 1998 th EU i l t d ll b f• n ecem er  e  mp emen e  an overa  an o  
virginiamycin, bacitracin, tylosin and spiramycin for growth 
promotion
• In 2000, VetStat was established, recording every antibiotic 
prescribed to production animals
• In 2002 fluoroquinolones were restricted to only be used if a          
current laboratory test shows that no other antibiotics can be 
used for that disease in that herd of production animals
• In 2002, EU voted to phase out all non-therapeutic use of 
antibiotics for growth promotion as of the beginning of 2006
EU and Danish government interventions - III 
• Action plan 2005 for reduction and prudent use of antimicrobials 
in swine, including 
- treatment guidelines for swine veterinary practitioners      
- direct risk communication with the individual swine veterinary 
practitioners with a high prescription rate
• Action plan 2007 for reduction and prudent use of antimicrobials 
in cattle, swine and poultry, including 
- direct risk communication including audit and supervision of        
prudent use of antimicrobials, every second year, of all 
veterinarians working with food-producing animals 
a task force was established in order to secure that there are-             
no economical relationships between veterinary practitioners 
and the pharmaceutical industry 
- treatment guidelines for cattle veterinary practitioners
EU and Danish government interventions - 2010
• Evidence based – including pharmacokinetics and –dynamics -
novel treatment guidelines for swine veterinary practitioners 
• A joint Antimicrobial and Resistance action plan between the        
Ministry of Health and the Ministry of Food, Agriculture and 
Fisheries
E t bli h t f th h ld l f t bl h d l l• s a s men  o  res o  va ues or accep a e er  eve s on 
mortality, antibiotic usage and certain welfare parameters in 
swine and cattle and enforced control in herds with levels above 
the threshold values 
• Mandatory action plans for reduction of antibiotic usage in swine 
herds above the threshold value for antibiotics usage – the so-         
called ‘yellow card’ initiative 
Guidelines for veterinary practitioners:
Evidence-based prudent use guidelines 
f ti i bi l t t t f ior an m cro a  rea men  o  p gs
May be used as a working tool 
 To optimize antimicrobial usage 
 To look up a specific disease and pathogen in the guidelines          
 To find, via drop-down lists, products, dosage and treatment period
 To obtain background information/evidence behind
Guideline available for download at www.dvfa.dk
Voluntary actions taken by the Danish agricultural industry
• The Danish cattle and broiler industries voluntarily stopped the 
non-therapeutic use of all antibiotics for growth promotion in 
February 1998
• The Danish swine industry voluntarily stopped all non-
therapeutic use of antibiotics in swine above 35 kg by April 
1998, and for all age groups by January 2000
• The Danish swine industry enforced a voluntary ban on all 
f fusage o  the high-risk antibiotics cephalosporins rom 1. July 
2010 (two-year ban)
Legislation regarding veterinary use of 
antimicrobial agents since 1993 - I    
• Order (DK) 142/1993: Restricted the use of extemporaneously 
prepared medicines; also called the cascade rule imposing      ,  
mandatory first priority to medicinal products approved for the relevant 
species, subsidiary approved for other species. 
• Directive (DK) 60/1995: Limits the veterinarians’ profit when 
distributing medicines to a maximum of 5–10% at sales. 
• Order (DK) 303/1995 and 304/1995: Limit the veterinary        
prescription to a maximum of 5 days of treatment in production 
animals. Exceptions only granted when a veterinary advisory service 
fcontract between the veterinarian and the armer was signed. In those 
cases, up to 35 days of treatment is allowed for a diagnosed disease or 
a disease that was expected in the pigs, calves and poultry, on the basis 
f th t i i ’ k l d f th h d ( i d b O d (DK)o  e ve er nar an s now e ge o  e er  rev se  y r er  
785/2010). By July 2010, veterinary advisory service contracts 
became obligatory for all larger pig and cattle herds in DK 
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Legislation regarding veterinary use of 
antimicrobial agents since 1993 - II    
• Order (DK) 303/1995: Treatment allowed only in diseased animals 
or animals in a well defined incubation period (metaphylaxis) and          
prophylactic use became illegal (revised by Order (DK) 
910/2006). 
• Mandatory registration by the veterinary practitioners of 
used, delivered and prescribed drugs to farmed animals. The 
information must be available for inspection by veterinary officials for 3 
years). Since 2001, reporting into the VetStat database has been 
mandatory. 
• Order (DK) 285/1996: Pharmacies and the pharmaceutical       
industry prohibited from offering economic incentives to 
veterinarians or others for the purpose of increasing product sales. 
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Legislation regarding veterinary use of 
antimicrobial agents since 1993 - III    
• Order (DK) 119/2002: Fluoroquinolones intended for 
injection were restricted to use by the veterinary practitioner only        . 
• Order (DK) 134/2003: Mandatory susceptibility testing in relation 
to use of fluoroquinolones for production animals, documenting the        
need. Notification of use of fluoroquinolones to the authorities is 
mandatory. 
O d (DK) 1319/2010 “ ll d”• r er  : The ye ow car  control of 
antimicrobial use in the pig production, imposing preventive measures 
in the herds with highest consumption per pig. In July 2010, an 
f “in ormation letter about the upcoming yellow card” was sent to the pig 
farmers, using the 20% highest number of ADD’s per pig.
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Running costs: < 1 mio. USD/year
Drug statistics before 2001
 have enabled us to demonstrate the effect of AGP 
intervention on antimicrobial resistance 
 have provided information on overall trends in usage
 h NOT id d i f ti i t t i lave  prov e n orma on on usage n arge an ma
species
 detailed modelling of effect of usage on resistance has not    
been possible
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VetStat - National monitoring of veterinary medicine use
F h dAll th ti di i d or eac recor :
- Farm ID
- Animal species
•  erapeu c me c nes an  
medicated feeds (since 2001: 
coocidiostatics for poultry)  
- Age group
- Disease category
• Valid data from 2001 and forwards
• Information on user level and
- Date
- Drug ID
  
about prescriber
- Drug quantity
- Prescriber ID
Running costs: ~0.5 million € per year
T d i i i bi l i i ( /k b )
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Resistance in Campylobacter jejuni - I
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Campylobacter jejuni – II
Resistance (%) in C. jejuni from human cases, Denmark 
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Campylobacter jejuni – III
Resistance (%) in C. jejuni from cattle, Denmark 
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Effect of interventions: 
Resistance to erythromycin 
among Enterococcus faecium from pigs and humans
80100
DANMAP 2010
     
and the consumption of macrolides in pigs
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Effect of interventions: 
Resistance to avoparcin
d th ti f i i b ilan  e consump on o  avoparc n n ro ers
Selective enrichment 2010:
No VanR enterococci from pigs and cattle
47% in E faecium from broilers  .  
VREF exist even 15 years after the ban!
=> introduction of a drug can lead to resistant bacteria which may increase if the drug is reintroduced
Effect of interventions: 
cephalosporines (3. og 4. gen) 
and fluoroquinolones
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0
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Development over the years (1)
• Still contains:
– ’basic surveillance’, consumption and prevalence 
of resistance in zoonotic bacteria and indicator 
bacteria, and pathogens
– Looks at relations between consumption and 
i tres s ance
– Strong integrated aspect in all relevant parts of the 
report
• Previously:
M f t i th– ore ocus on ve er nary pa ogens
– Only phenotypic testing of bacterial isolates
Development over the years (2)
• Now:
– More focus on emerging resistance (MRSA and ESBL)
– Zoonotic importance of other bacteria (Clostridium 
difficile)
– Zoonotic importance in indicator bacteria (E. coli and 
enterococcus spp ).
– More focus on epidemiology (origin of meat, travel 
relations, geography)
– Focus areas and textboxes with supporting information 
and studies
– More typing and genotypic testing
Why the changes?
• Change in diagnostic testing from public to private 
laboratories
• Change in other programmes that affect the passive sampling
• New resistance problems  
• More trade and travel activity
• Better tools and genetic methods
Spread of ESBL worldwide – more focus 
• Extended spectrum beta lactamase (ESBL)-producing 
bacteria are one of the fastest emerging resistance        
problems worldwide
• Use of 3rd and 4th generation cephalosporins may select      
for ESBL
ESBL-producing bacteria from animals
U til A t 2003 ESBL d i E li d S l ll f i l• n  ugus   -pro uc ng . co an  a mone a rom an ma s 
and food was not detected in Denmark
• The first cases of ESBL-producing bacteria was found in imported food and 
animals
• In 2005, the first ESBL-producing E. coli was detected in Danish animals  
• In 2006, ESBL-producing E. coli was detected in 7 cases and in 2007 it 
was 23 cases   
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Summary (ESBL)
• The use of more sensitive method (selective enrichment with 
ceftriaxone) revealed ESBL-producing E. coli , which were not found by 
standard monitoring
• The most important meat source seemed to be imported poultry meat. 
In addition, a high occurrence was found in Danish broilers at slaughter 
and cephalosporins have not been used for at least 10 years        
• As certain genotypes were dominant in E. coli from certain sources the 
genotype may be valuable for source attribution
• Some of the genotypes found among isolates from meat/animals are 
also found among E. coli causing infections in humans
MRSA in production animals and meat
•Pigs at slaughter in 2009 13% MRSA, 95% with CC398
•Pigs stables in 2010 16% MRSA, no in broilers or cattle at slaughter
Wh
Pigs are still the 
most important
y:
Other types?
Slaughter process?
Cross contamination?  
reservoir for 
CC398
DANMAP 2010
In the future
DANMAP will develop towards use of more genetics methods
– E.g. based on total sequencing
At DTU, we have are currently running a 36 mill DKK 
• The zoonotic aspect will be broader/different (E coli
project to develop the bioinformatics tool in a project 
called Center for Global Epidemiology (CGE).
     . , 
enterococci, S. aureus (MRSA CC398), C. difficile)
• More details about epidemiology and virulence
• Better addressing of co-selection
Meanwhile:
- Avoid use of critically important drugs as 
much as possible
K th t t l ti l- eep e o a  consump on as ow as 
possible
Summary, DANMAP
• DANMAP provides a baseline for antimicrobial resistance
• DANMAP records trends in antimicrobial resistance      
• Overall, levels of antimicrobial resistance reflect 
consumption of antimicrobials  
• With VetStat the possibility to demonstrate association 
between the use of antimicrobial agents and resistance is 
improved
• A tool to follow national interventions
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The EURL-AR 
Research group for antimicrobial resistance and 
molecular epidemiology
– 2 Professors
12 Scientists–  
– 8 PhD-students
– 10 Technicians 
1/3 Advisory tasks + Teaching
2/3 Research
Approach
Why an EURL-AR?
• The main purpose 
– to ensure the quality of antimicrobial susceptibility testing in the          
Member States 
– to harmonise the procedures and methodologies used
• Activities aim at implementing, from an analytical point of 
view, the provisions of monitoring of antimicrobial resistance 
set down in Directive 2003/99/EC of the European 
Parliament and of the Council of 17 November 2003 on the 
monitoring of zoonoses and zoonotic agents
T k f th EURL ARas s o  e -  
• Scientific advice and support to the EU Commission
• Co-ordination of National Reference Laboratories and provision of 
technical support
Contact to the network of NRL’s–      
– Annual workshops, training courses, site visits 
– Dissemination of knowledge and information (www.eurl-ar.eu)
– Collection of information on activities at the NRL’s
• Proficiency tests and quality assurance
• Confirmatory testing 
• Evaluation and development of analytic methods
WHO Global Foodborne Infections Network
→ Steering Committee 
Who is GFN? 
→ Members
B October 2011 1722 members from 184 co ntries
Some of the newest 
y  :     u
members are from: 
• American Samoa • Northern Mariana Islands
• Burkina Faso
• Comoros 
• Cook Islands 
• Qatar 
• Samoa
• Solomon Islands
• Eritrea 
• Iraq
• Lesotho
M h ll I l d
• Swaziland 
• Tajikistan 
• Tonga
T k d C i I l d• ars a  s an s • ur s an  a cos s an s
Vision and mission
The GFN vision: 
A world where all countries prevent foodborne
and other enteric infections
…and mission:
 
To enable countries to detect, control, and prevent foodborne
and other enteric infections by: 
• Building capacity for integrated surveillance
• Fostering collaboration among human health, veterinary, 
food and other relevant sectors  
GFN main activities
 (Inter)national Training Activities
St. Petersburg, Russian Federation
Moscow, Russian Federation
Poland
 External Quality Assurance System (EQAS) 
Thailand
Egypt
China
Guatemala
Tunisia
India
Papua New Guinea
Guam
Fiji
Cameroon
Kenya
Costa Rica Trinidad 
& Tobago
Argentina
Brazil Madagascar
South Africa
External Quality Assurance System (EQAS)
Objectives
• To have laboratories evaluate their performance of 
serotyping and antimicrobial susceptibility testing 
(AST)
• To improve quality of surveillance data
• To assess the quality of Salmonella serotyping
d AST i l b i ld idan   n a orator es wor w e
• To evaluate the effect of the training courses
To identify barriers for serotyping and AST•      
DTU Food, Technical University of Denmark58
Country Databank
Annual national and institutional data is collected:
– Number of Salmonella isolates identified/serotyped
– Top 15 Salmonella serotypes
Sources of Salmonella isolates–    
Status, November 2011:
> 1.6 million human isolates
New user interface under development:
> 450 000 non-human isolates
– Include other relevant pathogens
– Include antimicrobial susceptibility patterns
– Include explanatory factors (consumption data, trade, animal
59
       
production, meteorological data)
GFN on the web: www.who.int/gfn
Thanks for your attention!   
